China Isotope & Radiation (HKG:1763) said it is renewing a range of agreements with China National Nuclear Corp., or CNNC, according to a Hong Kong bourse filing Thursday.
Shares of the radiopharmaceuticals firm gained over 1% in morning trade Friday.
The renewals cover existing products and services supply frameworks, leasing agreements, engineering construction services frameworks, and certain financial services frameworks.
The agreements will be renewed for a three year period ending Dec. 31, 2028.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments